RxDoctor Payments Data

Shieun Hong

Adult Health · Garden Grove, CANPI 1922467299

Payments from drug & device makers

$3,870in general payments, 2019–2025

Across 189 payments — averaging $20.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Nestle Healthcare Nutrition Inc.$627
  • Fresenius USA Marketing, Inc.$398
  • Lilly USA, LLC$368
  • Novo Nordisk$268
  • Novartis$203
  • plus $991 from 13 others

What the payments were for

  • Food & beverage$3,870100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,870 in reported general payments places this provider in the 90th percentile of 785 adult health providers in California.

See all adult health providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban83$23,368
ZenpepLipase/Protease/Amylase24$16,173
CreonLipase/Protease/Amylase22$10,413
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog72$6,009
RhopressaNetarsudil Mesylate14$4,851
TradjentaLinagliptin14$3,697
EpogenEpoetin Alfa22$3,511
XareltoRivaroxaban12$3,407
Memantine Hcl106$3,204
JanumetSitagliptin Phos/Metformin Hcl22$3,193
JanuviaSitagliptin Phosphate11$3,166
Atorvastatin Calcium352$3,091
Potassium Chloride67$2,559
Memantine Hcl ErMemantine Hcl32$2,335
Tirosint-SolLevothyroxine Sodium11$1,562

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$28$23,36883 claims
AbbVieCreon$1,016$10,41322 claims
Boehringer IngelheimTradjenta$52$3,69714 claims
AmgenEpogen$62$3,51122 claims
Johnson & JohnsonXarelto$157$3,40712 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 785 adult health providers in California.

Other adult health in Garden Grove

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →